ERNEST HAWK to Cyclooxygenase 2 Inhibitors
This is a "connection" page, showing publications ERNEST HAWK has written about Cyclooxygenase 2 Inhibitors.
Connection Strength
1.367
-
An international randomised trial of celecoxib versus celecoxib plus difluoromethylornithine in patients with familial adenomatous polyposis. Gut. 2016 Feb; 65(2):286-95.
Score: 0.461
-
The APC and PreSAP trials: a post hoc noninferiority analysis using a comprehensive new measure for gastrointestinal tract injury in 2 randomized, double-blind studies comparing celecoxib and placebo. Clin Ther. 2012 Mar; 34(3):569-79.
Score: 0.093
-
C-reactive protein and risk of colorectal adenoma according to celecoxib treatment. Cancer Prev Res (Phila). 2011 Aug; 4(8):1172-80.
Score: 0.090
-
Coxibs and other nonsteroidal anti-inflammatory drugs in animal models of cancer chemoprevention. Cancer Prev Res (Phila). 2011 Nov; 4(11):1728-35.
Score: 0.089
-
The safety and efficacy of celecoxib in children with familial adenomatous polyposis. Am J Gastroenterol. 2010 Jun; 105(6):1437-43.
Score: 0.081
-
Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. Cancer Prev Res (Phila). 2009 Apr; 2(4):310-21.
Score: 0.076
-
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis. Circulation. 2008 Apr 22; 117(16):2104-13.
Score: 0.071
-
Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med. 2006 Aug 31; 355(9):873-84.
Score: 0.064
-
Cyclooxygenase inhibition in cancer prevention and treatment. Expert Opin Pharmacother. 2003 Dec; 4(12):2193-204.
Score: 0.053
-
Development of COX inhibitors in cancer prevention and therapy. Am J Clin Oncol. 2003 Aug; 26(4):S48-57.
Score: 0.051
-
Non-steroidal anti-inflammatory and cyclooxygenase-2-selective inhibitors in clinical cancer prevention trials. Prog Exp Tumor Res. 2003; 37:210-42.
Score: 0.049
-
The role of cyclooxygenase inhibitors in cancer prevention. Curr Pharm Des. 2002; 8(12):1035-62.
Score: 0.046
-
The future of colon cancer prevention. Ann N Y Acad Sci. 2001 Dec; 952:88-108.
Score: 0.046
-
Strategy for prevention of cancers of the esophagus. Ann N Y Acad Sci. 2014 Sep; 1325:108-26.
Score: 0.028
-
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials. Lancet. 2013 Aug 31; 382(9894):769-79.
Score: 0.025
-
The influence of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma. Cancer Prev Res (Phila). 2012 Jan; 5(1):61-72.
Score: 0.023
-
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000 Jun 29; 342(26):1946-52.
Score: 0.010
-
Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Cancer Res. 2000 Apr 01; 60(7):1864-70.
Score: 0.010